ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville

Inserm at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Inserm brings 8 presentations from 4 research groups to ASHG 2026 in Montréal. Its program centres on rare disease and cancer genetics, computational analysis, and therapeutic research at this meeting. Exposome and Heredity brings thyroid-cancer risk loci and breast-cancer findings from E3N-Generations, while BIGG: Biomedicine & Integrative Genetics & Genomics presents LPL variant interpretation across Mendelian disease and genetic predisposition.

OrganizationASHG 2026 Attendance
Inserm
Paris, France
2 Staff Scientists · 1 PI · 1 Faculty · 1 PhD Student
Exposome and Hereditycesp.inserm.fr/en/equipe/exposome-and-heredity?order=title&sort=asc
Dry lab~67 people
Studies the exposome and genetic terrain using E3N-Générations, EPIC, UK Biobank and metabolomics data. Examines cancers, cardio-metabolic diseases and age-related neurodegenerative diseases.
147 papers since 2024
›
Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case–control study in the European Prospective Investigation into Cancer and Nutrition (EPIC)
EBioMedicine, 2024
Long‐term exposure to air pollution and incidence of gastric and the upper aerodigestive tract cancers in a pooled European cohort: The ELAPSE project
International Journal of Cancer, 2024
Circulating inflammatory and immune response proteins and endometrial cancer risk: a nested case-control study and Mendelian randomization analyses
EBioMedicine, 2024
Source: OpenAlex author A5090492717
Funded by Inserm, ANR +11 more
›
Inserm · active
“Inserm”
ANR · active
“ANR (Agence nationale de la Recherche)”
La Ligue nationale contre le cancer · active
“La Ligue nationale contre le cancer”
+10 more on the lab page
Source: lab pages
8 platforms and techniques
›
Analyzes
Targeted metabolomics, Untargeted metabolomics
Techniques
Multivariate statistical analyses, Epidemiological models, Causal inference, Integrative -omics approaches, Genetic epidemiology, Bioinformatics
Source: lab pages
No openings posted
Poster
Wed Oct 21
2:30 pm
Large-scale association analysis identified new susceptibility risk loci for differentiated thyroid carcinoma by integrating the transcriptome and proteome.
Collaborators: Ca' Foscari University of Venice
TranscriptomeGenome-wide association studyProteomicsMendelian randomization
Poster
Wed Oct 21
2:30 pm
BIGG: Biomedicine & Integrative Genetics & Genomicsuniv-brest.fr/umr1078-genetique-genomique-biotechnologies/fr/page/bigg-biomedicine-and-integrative-genetics-genomics
Wet + dry lab~50 people
Studies genetic variants, constitutional genomics and microbiome in human disease. Focuses on cystic fibrosis, pancreatitis, polycystic kidney disease and neurodegenerative disorders.
4 platforms and techniques
›
Techniques
Metagenomics, Organoids, Biostatistics, Genetic epidemiology
Source: lab pages
No funding stated · No openings posted
Poster
Thu Oct 22
4:15 pm
Context-dependent variant interpretation from Mendelian disease to genetic predisposition: a proof-of-concept using LPL
Collaborators: Génétique, Génomique Fonctionnelle et Biotechnologies, Nanjing University +2 more
Clinical geneticsGenetic variationGenotype-phenotype correlationsInheritance patterns
Génétique Génomique fonctionnelle et Biotechnologies - GGB (UMR 1078)univ-brest.fr/umr1078-genetique-genomique-biotechnologies/fr
Wet + dry lab~109 people
Studies genetic variants, microbiome and RNA splicing using RNA-seq and synthetic vectors. Targets genetic, complex and cancer diseases.
23 papers since 2024
›
PFMG2025–integrating genomic medicine into the national healthcare system in France
The Lancet Regional Health - Europe, 2025
Combining full-length gene assay and SpliceAI to interpret the splicing impact of all possible SPINK1 coding variants
Human Genomics, 2024
Short Tandem Repeats in the era of next-generation sequencing: from historical loci to population databases
European Journal of Human Genetics, 2024
Source: OpenAlex author A5011453874
Funded by Inserm, Ligue contre le Cancer +1 more
›
Inserm, Projet de recherche international (PRI) · 2025 call; 2026-2030 project
“This next step is supported by dedicated funding from Inserm through the 2025 edition of the Projet de recherche international (PRI) call.”
Ligue contre le Cancer · active
“Ce projet est soutenu par la Ligue contre le Cancer et la Fondation pour l’Avenir.”
Fondation pour l’Avenir · active
“Ce projet est soutenu par la Ligue contre le Cancer et la Fondation pour l’Avenir.”
Source: lab pages
9 platforms and techniques
›
Runs
SynNanoVect
Techniques
RNA-seq, RT-qPCR, Vecteurs lentiviraux inductibles à la doxycycline, Culture cellulaire 3D, CRISPR-Cas, Imagerie microscopique en temps réel, Intelligence artificielle et traitement d’images, Levure
Source: lab pages
No openings posted
Poster
Wed Oct 21
2:30 pm
A methodological framework for a pan-European genomic reference resource: data harmonization, federated analyses, and early results from the Genome of Europe project
Collaborators: Génétique, Génomique Fonctionnelle et Biotechnologies, University of Lisbon +1 more
BioinformaticsPopulation geneticsPharmacogenomicsStatistical genetics
TAGC UMR U1090 — Theories and Approaches of Genomic Complexitytagc.univ-amu.fr/index.php/fr
Wet + dry lab~43 people
Studies genomic complexity using TGML high-throughput sequencing, single-cell RNA-seq, ChIP-seq, ATAC-seq and CRISPR screens. Targets regulatory networks, biomarkers and therapies for multifactorial disease.
5 papers since 2024
›
Cardiac and Digestive Forms of Chagas Disease: An Update on Pathogenesis, Genetics, and Therapeutic Targets
Mediators of Inflammation, 2025
Distinct Inflammatory Responses of hiPSC-Derived Endothelial Cells and Cardiomyocytes to Cytokines Involved in Immune Checkpoint Inhibitor-Associated Myocarditis
Cells, 2025
Sex Differences in Chagas Cardiomyopathy: a Comprehensive Review
Current Heart Failure Reports, 2025
Source: OpenAlex author A5038569584
Funded by ANR, ANR +5 more
›
ANR, Hu-Thy-L · ANR-21
“ANR Hu Thy L ... Deciphering a genetic control of Human Thymopoiesis at the TCRA-TCRD Locus”
ANR, REMEDY · ANR-21
“ANR REMEDY ... Régulation des enhancers par la méthylation de l'ADN chez les mammifères”
ANR, MAD-BIO · ANR-22
“ANR MADBIO ... Malaria integrative Analysis to Discover Biomarkers of Infection Outcome”
+4 more on the lab page
Source: lab pages
16 platforms and techniques
›
Runs
Illumina NextSeq-500, Chromium controller, single-cell RNA-seq, ChIP-seq, ATAC-seq, Agilent high-resolution microarray scanner, DNA chips, genome-wide CRISPR screening
Techniques
CRISPR KO/KI/interference/activation, STARR-seq, MPRA, qPCR and qRT-PCR, Dual-luciferase reporter assay, EMSA, Western blot, Drosophila and mouse models
Source: lab pages
Currently hiring
›
“OPEN CALL FOR A PRINCIPAL INVESTIGATOR IN COMPUTATIONAL, SYSTEMS AND INTEGRATIVE BIOLOGY”
Source: lab positions page
Poster
Wed Oct 21
2:30 pm
2 more presenters — research group not yet identified

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHG 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Inserm

Tell us what you sell and we’ll find the people at Inserm most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction